A 2024 umbrella meta-analysis reveals that magnesium supplementation can meaningfully contribute to blood pressure reduction when used strategically. Patients taking 400 mg or more daily for at least 12 weeks experienced reductions of 6.38 mmHg in systolic pressure and 3.71 mmHg in diastolic pressure, with the most significant benefits observed in individuals with metabolic disorders and pre-existing magnesium deficiency.
The research underscores an important clinical distinction: magnesium supplementation works optimally as part of a comprehensive cardiovascular management plan rather than as a standalone treatment. The mineral achieves its effects through multiple physiological mechanisms, including promotion of nitric oxide production and enhancement of endothelial function, which collectively reduce vascular resistance.
These findings suggest that clinicians should consider magnesium status assessment in hypertensive patients, particularly those with concurrent metabolic conditions, while maintaining adherence to established antihypertensive therapies.
Read the full article on GMJ Newsroom.
Was this article helpful?
